This inventor holds 1 USPTO granted patent. Top assignee: Dong-A St Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yoojin Kim - Innovator in Cancer Treatment
Introduction
Yoojin Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies.
Latest Patents
Yoojin Kim holds a patent for an "Anti-DR5 antibody and use thereof." This invention relates to an antibody that specifically binds to death receptor 5 (DR5) and has the capability of killing cancer cells. The patent emphasizes the improved affinity of the anti-DR5 antibody to DR5, its stability, and its effectiveness in targeting and eliminating cancer cells.
Career Highlights
Yoojin Kim is associated with Dong-a St Co., Ltd., where he continues to advance his research in the field of oncology. His work is pivotal in developing therapeutic options for cancer patients.
Collaborations
Yoojin collaborates with notable colleagues, including Hyounmie Doh and Dongsop Lee, who contribute to his research endeavors.
Conclusion
Yoojin Kim's innovative work in developing anti-DR5 antibodies showcases his commitment to improving cancer treatment. His contributions are vital in the ongoing fight against cancer, and his research holds promise for future therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile